An Observational study, Evaluating Alemtuzumab as Rescue Therapy in a Cohort of 16 Aggressive Multiple Sclerosis Patients who had previously treated with mitoxantrone

Trial Profile

An Observational study, Evaluating Alemtuzumab as Rescue Therapy in a Cohort of 16 Aggressive Multiple Sclerosis Patients who had previously treated with mitoxantrone

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Dec 2015

At a glance

  • Drugs Alemtuzumab (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Dec 2015 New trial record
    • 01 Jan 2015 Status changed from active, no longer recruiting to completed according to results presented at the 2014 Congress of European Neurology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top